Simplex Trading’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4
Closed -$17 10125
2026
Q1
$14 Buy
+4
New +$17 ﹤0.01% 8922
2025
Q2
Sell
-1,130
Closed -$8.22K 9555
2025
Q1
$9K Buy
+1,130
New +$10.6K ﹤0.01% 7194
2024
Q3
Sell
-3,510
Closed -$33K 9373
2024
Q2
$27K Buy
3,510
+3,113
+784% +$29.6K ﹤0.01% 6650
2024
Q1
$6K Sell
397
-2,169
-85% -$35.1K ﹤0.01% 7939
2023
Q4
$35K Buy
+2,566
New +$29.4K ﹤0.01% 6432
2023
Q3
Sell
-13,796
Closed -$233K 9614
2023
Q2
$234K Buy
13,796
+11,951
+648% +$175K ﹤0.01% 4121
2023
Q1
$25K Sell
1,845
-9,668
-84% -$103K ﹤0.01% 6683
2022
Q4
$75K Sell
11,513
-26,298
-70% -$158K ﹤0.01% 5397
2022
Q3
$199K Sell
37,811
-15,472
-29% -$95.5K ﹤0.01% 4616
2022
Q2
$253K Buy
53,283
+49,686
+1,381% +$307K ﹤0.01% 4321
2022
Q1
$30K Buy
+3,597
New +$33.2K ﹤0.01% 7774
2021
Q4
Sell
-164
Closed -$2.5K 11264
2021
Q3
$3K Hold
164
﹤0.01% 9451
2021
Q2
$3K Sell
164
-1,336
-89% -$26.3K ﹤0.01% 9637
2021
Q1
$29K Buy
+1,500
New +$34.9K ﹤0.01% 7154
2020
Q4
Sell
-1,565
Closed -$34.3K 8927
2020
Q3
$39K Sell
1,565
-200
-11% -$4.99K ﹤0.01% 5849
2020
Q2
$53K Buy
+1,765
New +$54K ﹤0.01% 5442

Other funds holding RCEL

Simplex Trading's RCEL Position: Q2 2026 in Review

Simplex Trading sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 4 shares — an estimated $17 sold.

Simplex Trading first reported a position in RCEL in Q2 2020 and held it in 16 quarters. The position peaked at $253K in Q2 2022. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Simplex Trading reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 4 Avita Medical shares in Q2 2026, an estimated $17.
  • Simplex Trading first reported a position in Avita Medical in Q2 2020 and held it in 16 quarters.
  • Simplex Trading's Avita Medical position peaked at $253K in Q2 2022.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.